Yazar "Cakmak Karaer, Isil" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    Clinical trial to evaluate the outcome of canal wall up and canal wall down tympanomastoidectomy
    (2020) Cakmak Karaer, Isil; Ensari, Nuray
    Aim: The aim of this study was to evaluate the hearing outcomes of chronic suppurative otitis media surgery. Chronic suppurative otitis media (CSOM) surgery composed of two procedure; canal wall up mastoidectomy (CWU) and canal wall down mastoidectomy (CWD). Material and Methods:The study included 29 patients with CSOM diagnosis and patients a mean age of 37.02 ± 2.4 years (y). The demographic features (age, gender), clinical features and intraoperative findings of the patients were recorded. Patients’ hearing was evaluated with pure tone audiometry (PTA) at 0.5, 1, 2, 4 and 8 kHz and pre-postoperative air bone gap (ABG) difference. Pre- and post-operative air-bone gap (ABG) at 12 months after ossiculoplasty. There were 8 patients who underwent CWD and 21 patients who underwent CWU. Results: TWhen preoperative and postoperative ABG for the patients are compared, there were statistically significant differences identified at 0.5, 1, 2 and 8 kHz. However, there was no statistically significant difference identified at 4 kHz. Conclusion: Regardless to the surgical technique, statistically significant levels of hearing gain were provided at 0.5, 1, 2 and 8 kHz; however, there was no hearing gain at 4 kHz after the surgical procedure.
  • Küçük Resim
    Öğe
    Does short-term montelukast treatment cause sleep problems or psychiatric problems in children? A preliminary study
    (2020) Donmez, Yunus Emre; Cakmak Karaer, Isil
    Aim: Montelukast is one of the treatment choices for symptomatic allergic rhinitis and asthma in children. Various researches emphasized that montelukast use causes neuropsychiatric side effects. The aim of this study was to investigate the effect of short-term montelukast use on children's sleep habits, and whether sleep-related problems and psychiatric problems may occur.Material and Methods: This prospective study was conducted with 30 children. Psychiatric disorders and symptoms, sleep habits, sleep-related problems were evaluated before the use of montelukast. All of these evaluations were repeated at 4th and 8th week of treatment. Psychiatric assessment was performed with the Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version – Turkish. Sleep habits, sleep-related problems were assessed using the Children Sleep Habits Questionnaire Short Form (CSHQ-S) and the Pediatric Sleep Questionnaire (PSQ).Results: According to the psychiatric assessment, no psychiatric disease or symptom was identified before treatment and at the 4th and 8th week of treatment. The CSHQ-S and PSQ responses were evaluated and there was no significant difference between results obtained before treatment and at the 4th and 8th weeks of treatment.Conclusion: The results revealed that short-term montelukast use is safe and do not cause changes sleep habits, sleep-related problems or psychiatric problems in children. Long-term follow-up studies with high numbers of participants are needed to test these results and evaluate the possible neuropsychiatric side effects of long-term montelukast use.